	osteoporosis
benefit
non-compliance
fracture
bisphosphonates
	non-compliant use
osteoporotic fracture
persistent bisphosphonate use
compliance
low compliance
fractures
daily
osteoporosis
Results The study cohort
treatment compliance
follow-up
risk
patients
day interval
treatment benefit
bisphosphonate therapy
drugs
study period
analysis
categories
women
female users
year
maximal treatment benefit
hormone replacement therapy
bisphosphonates
poorer compliance
non-compliant
MPR
similar
medication
once-weekly
Data
days supply
interval
infrequent
users
results
PHARMO-RLS

